EQL Pharma AB (publ) (FRA:7JK)
Germany
· Delayed Price · Currency is EUR 4.490
-0.015 (-0.33%)
Last updated: Dec 4, 2025, 3:29 PM CET
EQL Pharma AB Revenue
EQL Pharma AB had revenue of 86.38M SEK in the quarter ending September 30, 2025, with 1.33% growth. This brings the company's revenue in the last twelve months to 399.07M, up 26.14% year-over-year. In the fiscal year ending March 31, 2025, EQL Pharma AB had annual revenue of 373.52M with 41.39% growth.
Revenue (ttm)
399.07M SEK
Revenue Growth
+26.14%
P/S Ratio
3.73
Revenue / Employee
19.00M SEK
Employees
21
Market Cap
134.75M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 373.52M | 109.35M | 41.39% |
| Mar 31, 2024 | 264.17M | 4.26M | 1.64% |
| Mar 31, 2023 | 259.91M | -149.84M | -36.57% |
| Mar 31, 2022 | 409.75M | 230.61M | 128.73% |
| Mar 31, 2021 | 179.14M | 107.11M | 148.70% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |